Company page

Geron Corporation

Geron Corporation, trading under the ticker GERN, is a public company based in the United States with a market capitalization of approximately $808.3 million. The company is focused on developing innovative therapies for cancer treatment. Geron is committed to advancing its research and product pipeline to address unmet medical needs in oncology.